Cardinal Health
1,222 hedge funds and large institutions have $32.5B invested in Cardinal Health in 2025 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 438 increasing their positions, 457 reducing their positions, and 126 closing their positions.
16% more call options, than puts
Call options by funds: $386M | Put options by funds: $333M
1.04% more ownership
Funds ownership: 86.11% → 87.15% (+1%)
4% less repeat investments, than reductions
Existing positions increased: 438 | Existing positions reduced: 457
7% less first-time investments, than exits
New positions opened: 117 | Existing positions closed: 126
2% less funds holding
Funds holding: 1,253 → 1,222 (-31)
6% less capital invested
Capital invested by funds: $34.5B → $32.5B (-$2.03B)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$542M |
| 2 |
Holocene Advisors
New York
|
+$174M |
| 3 |
BlackRock
New York
|
+$142M |
| 4 |
Barclays
London,
United Kingdom
|
+$128M |
| 5 |
Squarepoint
New York
|
+$116M |
Top Sellers
CAH Hedge Fund Activity: Q3 2025 in Review
1,222 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q3 2025, worth a combined $32.5B — down 5.9% from $34.5B a quarter earlier.
Sellers outnumbered buyers: 126 funds closed out of CAH and 117 opened new positions — a net loss of 9 holders — while 457 trimmed existing stakes and 438 added.
The largest buyer was Wellington Management Group, adding an estimated $542M. The largest seller was Marshall Wace, cutting an estimated $288M.
- 1,222 institutional investors held Cardinal Health (CAH) as of Q3 2025, down from 1,253 in Q2 2025.
- Funds reported $32.5B of Cardinal Health stock for Q3 2025, down 5.9% quarter-over-quarter.
- 117 funds opened new Cardinal Health positions in Q3 2025 and 126 closed out, a net change of -9 holders.
- The largest Cardinal Health buyer in Q3 2025 was Wellington Management Group, an estimated $542M added.
- The largest Cardinal Health seller in Q3 2025 was Marshall Wace, an estimated $288M sold.
Based on aggregated 13F filings for Q3 2025.